Camber Capital Management LP Novartis Ag Call Options Transaction History

Camber Capital Management LP

  • $3.15 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022
SELL
$80.11 - $90.62 $80.1 Million - $90.6 Million
-1,000,000 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $79.7 Million - $88.1 Million
-1,000,000 Reduced 50.0%
1,000,000 $87.5 Million
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $164 Million - $190 Million
2,000,000 New
2,000,000 $164 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Camber Capital Management LP Portfolio

Follow Camber Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email